X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (70044) 70044
Book Review (12790) 12790
Publication (2606) 2606
Newsletter (1895) 1895
Magazine Article (505) 505
Conference Proceeding (333) 333
Book Chapter (170) 170
Book / eBook (76) 76
Newspaper Article (73) 73
Dissertation (41) 41
Trade Publication Article (32) 32
Reference (29) 29
Transcript (24) 24
Web Resource (23) 23
Paper (7) 7
Data Set (3) 3
Government Document (3) 3
Archival Material (1) 1
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (58798) 58798
humans (53421) 53421
antihypertensive agents - therapeutic use (38382) 38382
male (32558) 32558
hypertension - drug therapy (30360) 30360
female (27408) 27408
middle aged (21309) 21309
hypertension (20735) 20735
aged (17254) 17254
blood pressure - drug effects (15336) 15336
adult (14873) 14873
animals (14045) 14045
antihypertensive agents - pharmacology (13646) 13646
hypertension - physiopathology (10897) 10897
antihypertensive agents - administration & dosage (10082) 10082
blood pressure (9718) 9718
rats (8809) 8809
peripheral vascular disease (8763) 8763
risk factors (8378) 8378
antihypertensive agents - adverse effects (8367) 8367
pharmacology & pharmacy (8077) 8077
treatment outcome (8045) 8045
hypertension - complications (6966) 6966
antihypertensive drugs (6760) 6760
abridged index medicus (6704) 6704
blood-pressure (6399) 6399
antihypertensive agents (6296) 6296
drug therapy, combination (5775) 5775
cardiac & cardiovascular systems (5248) 5248
medicine, general & internal (5233) 5233
aged, 80 and over (4535) 4535
time factors (4531) 4531
drug therapy (4466) 4466
angiotensin-converting enzyme inhibitors - therapeutic use (4367) 4367
hypertension - diagnosis (3801) 3801
research (3677) 3677
mortality (3546) 3546
hypertension - epidemiology (3486) 3486
double-blind method (3468) 3468
prospective studies (3361) 3361
dose-response relationship, drug (3359) 3359
risk (3215) 3215
follow-up studies (3192) 3192
care and treatment (3180) 3180
prevalence (3160) 3160
heart rate - drug effects (3136) 3136
blood pressure - physiology (3038) 3038
calcium channel blockers - therapeutic use (2951) 2951
hypertension - therapy (2829) 2829
adolescent (2787) 2787
ophthalmology (2741) 2741
clinical trials as topic (2700) 2700
adrenergic beta-antagonists - therapeutic use (2662) 2662
therapy (2635) 2635
retrospective studies (2589) 2589
management (2568) 2568
diuretics - therapeutic use (2567) 2567
medicine & public health (2506) 2506
analysis (2489) 2489
hypertension - etiology (2455) 2455
prevention (2453) 2453
disease (2423) 2423
old medline (2412) 2412
rats, inbred shr (2412) 2412
diuretics (2399) 2399
randomized controlled trials as topic (2265) 2265
health aspects (2216) 2216
angiotensin (2120) 2120
prognosis (2051) 2051
cardiovascular diseases - prevention & control (2039) 2039
angiotensin receptor antagonists (2033) 2033
diabetes (2033) 2033
age factors (2000) 2000
hemodynamics - drug effects (1988) 1988
urology & nephrology (1975) 1975
internal medicine (1949) 1949
pregnancy (1948) 1948
stroke (1939) 1939
rats, sprague-dawley (1837) 1837
patient compliance (1834) 1834
hypertension, pulmonary - drug therapy (1832) 1832
losartan (1829) 1829
drugs (1825) 1825
intraocular pressure - drug effects (1799) 1799
tetrazoles - therapeutic use (1784) 1784
drug combinations (1734) 1734
trial (1721) 1721
practice guidelines as topic (1704) 1704
hypertension - blood (1702) 1702
antihypertensive agents - pharmacokinetics (1694) 1694
glaucoma (1694) 1694
renin-angiotensin system - drug effects (1684) 1684
cross-sectional studies (1681) 1681
cardiovascular disease (1672) 1672
hypertension - prevention & control (1644) 1644
blood pressure monitoring, ambulatory (1637) 1637
rats, wistar (1630) 1630
angiotensin-converting enzyme inhibitors - pharmacology (1606) 1606
cardiology (1561) 1561
hypertension - metabolism (1560) 1560
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (50) 50
Online Resources - Online (20) 20
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Baycrest Hospital - Wellness Library (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (61032) 61032
German (2840) 2840
French (1789) 1789
Russian (1682) 1682
Japanese (1043) 1043
Spanish (1006) 1006
Italian (800) 800
Chinese (526) 526
Polish (387) 387
Portuguese (227) 227
Swedish (210) 210
Danish (191) 191
Czech (173) 173
Dutch (167) 167
Norwegian (155) 155
Hungarian (147) 147
Romanian (120) 120
Ukrainian (66) 66
Croatian (57) 57
Hebrew (57) 57
Finnish (56) 56
Bulgarian (51) 51
Turkish (43) 43
Serbian (35) 35
Slovak (32) 32
Korean (20) 20
Lithuanian (9) 9
Bosnian (4) 4
Icelandic (2) 2
Slovenian (2) 2
Afrikaans (1) 1
Armenian (1) 1
Greek (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1977, Handbook of experimental pharmacology : New series, ISBN 9783540075943, Volume 39., xiv, 779
Book
1967, Medicinal chemistry, a series of monographs, v. 7, 534
Book
JAMA, ISSN 0098-7484, 11/2004, Volume 292, Issue 18, pp. 2217 - 2225
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Index Medicus | Abridged Index Medicus | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
Journal Article
Endocrine Journal, ISSN 0918-8959, 2014, Volume 61, Issue 4, pp. 365 - 372
The effects of exenatide on glycemic control, lipid metabolism, blood pressure, and gastrointestinal symptoms were investigated in obese Japanese patients with... 
Obesity | Incretin | Type 2 diabetes mellitus | Exenatide | GLYCEMIC CONTROL | GLP-1 | ENDOCRINOLOGY & METABOLISM | Follow-Up Studies | Nausea - chemically induced | Obesity - drug therapy | Humans | Middle Aged | Gastrointestinal Agents - administration & dosage | Antihypertensive Agents - administration & dosage | Anti-Obesity Agents - adverse effects | Male | Diabetes Mellitus, Type 2 - metabolism | Weight Loss - drug effects | Obesity - blood | Anti-Obesity Agents - therapeutic use | Peptides - administration & dosage | Hypoglycemic Agents - administration & dosage | Glucagon-Like Peptide 1 - agonists | Injections, Subcutaneous | Venoms - administration & dosage | Adult | Female | Diabetes Mellitus, Type 2 - complications | Body Mass Index | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Anti-Obesity Agents - administration & dosage | Obesity - complications | Venoms - adverse effects | Japan | Antihypertensive Agents - therapeutic use | Anticholesteremic Agents - adverse effects | Antihypertensive Agents - adverse effects | Obesity - metabolism | Diabetes Mellitus, Type 2 - blood | Anticholesteremic Agents - therapeutic use | Anticholesteremic Agents - administration & dosage | Gastrointestinal Agents - therapeutic use | Venoms - therapeutic use | Aged | Gastrointestinal Agents - adverse effects | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Peptides - adverse effects | Peptides - therapeutic use | Index Medicus
Journal Article
Medical Care, ISSN 0025-7079, 4/2009, Volume 47, Issue 4, pp. 395 - 402
Background: Intensification of pharmacotherapy in persons with poorly controlled chronic conditions has been proposed as a clinically meaningful process... 
Hypertension | Hyperlipidemias | Trajectory control | Diabetes mellitus | Ales | Predisposing factors | Medications | Internships | Diabetes | Hemoglobins | Cardiovascular disease | Hyperlipidemia | Quality of health care | UNITED-STATES | cardiovascular disease | hyperlipidemia | quality of health care | MANAGEMENT | CHOLESTEROL | HYPERTENSION CONTROL | TRANSLATING RESEARCH | diabetes mellitus | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HEALTH CARE SCIENCES & SERVICES | BLOOD-PRESSURE CONTROL | HEALTH POLICY & SERVICES | CORONARY-HEART-DISEASE | hypertension | TYPE-2 DIABETES-MELLITUS | OF-CARE | PERFORMANCE-MEASURES | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Hyperlipidemias - drug therapy | Middle Aged | Risk Factors | Diabetes Mellitus - drug therapy | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | California | Antihypertensive Agents - therapeutic use | Managed Care Programs | Outcome and Process Assessment (Health Care) | Drug Therapy - standards | Hypoglycemic Agents - administration & dosage | Drug Therapy - methods | Hypolipidemic Agents - administration & dosage | Female | Aged | Hypolipidemic Agents - therapeutic use | Quality Indicators, Health Care - standards | Chronic Disease - drug therapy | Performance evaluation | Validity | Drug therapy | Risk factors | Quality of care | Chronic illnesses | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, pp. e98961 - e98961
Journal Article
Hypertension, ISSN 0194-911X, 06/2008, Volume 51, Issue 6, pp. 1537 - 1544
Journal Article